Below are links to recent noteworthy findings. The second article reinforces the importance of screening.

1)  vTv Therapeutics Announces Positive Results from Part 2 of the Phase 2 Simplici-T1 Study of TTP399, a Potential First-in-Class Oral Adjunctive Therapy for Patients with Type 1 Diabetes

2)  General Population Screening Reduces Life Threatening Diabetic Ketoacidosis, New Research Shows

Meredith Cocke
RIV Volunteer